They are not yet approved for use in the UK, EU, or USA as of the time of publication
Their approach integrates advanced regenerative medicine techniques, including the use of peptides like TB 500 and BPC 157, as part of comprehensive wellness therapy plans
Clinical observations suggest tesofensine may increase resting energy expenditure by approximately 6% after 14 days of treatment, directly attributable to the compound rather than external factors
GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis
GLP-1 (Glucagon-like peptide-1) injections are a class of medications that mimic the action of the natural GLP-1 hormone in the body, stimulating insulin secretion, suppressing appetite, and delaying gastric emptying, thereby promoting weight loss